Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sven G Meuth

Showing results (1-10 of 656) with videos related to

Pageof 66
Sort By:
Der Nervenarzt|September 26, 2024
[Neuroimmunology without limits]Sven G Meuth
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 21, 2021
Stable multiple sclerosis patients on anti-CD20 therapy should go on extended interval dosing-"Yes"Leoni Rolfes, Sven G Meuth
Therapeutic Advances in Neurological Disorders|September 3, 2013
Targeting ion channels for the treatment of autoimmune neuroinflammationStefan Bittner, Sven G Meuth
European Neurology|February 13, 2010
Multifocal motor neuropathy: update on clinical characteristics, pathophysiological concepts and therapeutic optionsSven G Meuth, Christoph Kleinschnitz
Drugs|June 3, 2015
Pharmacological Approaches to Delaying Disability Progression in Patients with Multiple SclerosisHeinz Wiendl, Sven G Meuth
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 19, 2019
Brain fibrinogen deposition plays a key role in MS pathophysiology - NoKerstin Göbel, Sven G Meuth
Neural Regeneration Research|July 23, 2015
Blood-brain barrier modeling: challenges and perspectivesTobias Ruck, Stefan Bittner, Sven G Meuth
Journal of Neurology|March 21, 2009
Recent clinical trials and future therapiesSven G Meuth, Christoph Kleinschnitz, Heinz Wiendl
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|July 2, 2009
CD8+ T cells and neuronal damage: direct and collateral mechanisms of cytotoxicity and impaired electrical excitabilityNico Melzer, Sven G Meuth, Heinz Wiendl
International MS Journal|September 24, 2008
The trials and errors in MS therapyChristoph Kleinschnitz, Sven G Meuth, Heinz Wiendl
Pageof 66

Showing results (1-10 of 656) with videos related to

Sort By:
Pageof 66
Der Nervenarzt|September 26, 2024
[Neuroimmunology without limits]Sven G Meuth
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 21, 2021
Stable multiple sclerosis patients on anti-CD20 therapy should go on extended interval dosing-"Yes"Leoni Rolfes, Sven G Meuth
Therapeutic Advances in Neurological Disorders|September 3, 2013
Targeting ion channels for the treatment of autoimmune neuroinflammationStefan Bittner, Sven G Meuth
European Neurology|February 13, 2010
Multifocal motor neuropathy: update on clinical characteristics, pathophysiological concepts and therapeutic optionsSven G Meuth, Christoph Kleinschnitz
Drugs|June 3, 2015
Pharmacological Approaches to Delaying Disability Progression in Patients with Multiple SclerosisHeinz Wiendl, Sven G Meuth
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 19, 2019
Brain fibrinogen deposition plays a key role in MS pathophysiology - NoKerstin Göbel, Sven G Meuth
Neural Regeneration Research|July 23, 2015
Blood-brain barrier modeling: challenges and perspectivesTobias Ruck, Stefan Bittner, Sven G Meuth
Journal of Neurology|March 21, 2009
Recent clinical trials and future therapiesSven G Meuth, Christoph Kleinschnitz, Heinz Wiendl
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|July 2, 2009
CD8+ T cells and neuronal damage: direct and collateral mechanisms of cytotoxicity and impaired electrical excitabilityNico Melzer, Sven G Meuth, Heinz Wiendl
International MS Journal|September 24, 2008
The trials and errors in MS therapyChristoph Kleinschnitz, Sven G Meuth, Heinz Wiendl
Pageof 66